Fig. 3From: Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer’s disease and other neurodegenerative diseasesThe Association between CSF p-tau181 and t-tau Stratified according to AD neuropathologic scores. (A) The distribution plots and Deming regression line showed different trends between CERAD scores lower than or equal to sparse and CERAD higher than or equal to moderate, suggesting a higher CSF p-tau181 in CERAD higher than or equal to moderate. (B) In a subgroup of patients with CERAD higher than or equal to moderate, the distribution plots and regression line showed different trends between Braak NFT stage ≤II and Braak NFT stage ≥III suggesting a higher CSF p-tau181 in Braak NFT stages ≥IIIBack to article page